Repurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million

Bulletin Express06-17

Hangzhou Tigermed Consulting Co., Ltd. (abbrev. “TIGERMED”) disclosed a Next Day Disclosure Return on 17 June 2026, detailing the latest share repurchase executed on the Shenzhen Stock Exchange.

On 17 June 2026, TIGERMED repurchased 833,600 A-shares via on-market transactions at prices ranging from RMB 38.78 to RMB 39.97 per share. The aggregate consideration reached RMB 33.03 million, implying a volume-weighted average cost of roughly RMB 39.62 per share. All repurchased shares are being held as treasury shares.

Following this transaction, the company’s treasury stock increased from 23.67 million to 24.50 million shares. The number of issued shares outstanding (excluding treasury shares) declined from 714.23 million to 713.40 million, a reduction of 0.12%. Total issued share capital remains unchanged at 737.90 million shares, as the repurchased shares have not been cancelled.

The filing affirms that the repurchase complied with both Hong Kong Stock Exchange rules and the relevant Shenzhen Stock Exchange regulations. No additional information regarding the repurchase mandate or future issuance restrictions was provided in the disclosure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191083280?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191083280","market":"hk","top_or_hot":-1,"title":"Repurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (abbrev. “TIGERMED”) disclosed a Next Day Disclosure Return on 17 June 2026, detailing the latest share repurchase executed on the Shenzhen Stock Exchange.</p>\n<p>On 17 June 2026, TIGERMED repurchased 833,600 A-shares via on-market transactions at prices ranging from RMB 38.78 to RMB 39.97 per share. The aggregate consideration reached RMB 33.03 million, implying a volume-weighted average cost of roughly RMB 39.62 per share. All repurchased shares are being held as treasury shares.</p>\n<p>Following this transaction, the company’s treasury stock increased from 23.67 million to 24.50 million shares. The number of issued shares outstanding (excluding treasury shares) declined from 714.23 million to 713.40 million, a reduction of 0.12%. Total issued share capital remains unchanged at 737.90 million shares, as the repurchased shares have not been cancelled.</p>\n<p>The filing affirms that the repurchase complied with both Hong Kong Stock Exchange rules and the relevant Shenzhen Stock Exchange regulations. No additional information regarding the repurchase mandate or future issuance restrictions was provided in the disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Repurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRepurchase Update: TIGERMED Buys Back 0.83 Million A-Shares, Treasury Stock Rises to 24.50 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-17 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (abbrev. “TIGERMED”) disclosed a Next Day Disclosure Return on 17 June 2026, detailing the latest share repurchase executed on the Shenzhen Stock Exchange.</p>\n<p>On 17 June 2026, TIGERMED repurchased 833,600 A-shares via on-market transactions at prices ranging from RMB 38.78 to RMB 39.97 per share. The aggregate consideration reached RMB 33.03 million, implying a volume-weighted average cost of roughly RMB 39.62 per share. All repurchased shares are being held as treasury shares.</p>\n<p>Following this transaction, the company’s treasury stock increased from 23.67 million to 24.50 million shares. The number of issued shares outstanding (excluding treasury shares) declined from 714.23 million to 713.40 million, a reduction of 0.12%. Total issued share capital remains unchanged at 737.90 million shares, as the repurchased shares have not been cancelled.</p>\n<p>The filing affirms that the repurchase complied with both Hong Kong Stock Exchange rules and the relevant Shenzhen Stock Exchange regulations. No additional information regarding the repurchase mandate or future issuance restrictions was provided in the disclosure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1191083280","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191083280","pubTimestamp":1781688318,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (abbrev. “TIGERMED”) disclosed a Next Day Disclosure Return on 17 June 2026, detailing the latest share repurchase executed on the Shenzhen Stock Exchange. On...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"回购更新：泰格医药回购83万股A股库存股升至2450万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (abbrev. “TIGERMED”) disclosed a Next Day Disclosure Return on 17 June 2026, detailing the latest share repurchase executed on the Shenzhen Stock Exchange.\nOn 17 June 2026, TIGERMED repurchased 833,600 A-shares via on-market transactions at prices ranging from RMB 38.78 to RMB 39.97 per share. The aggregate consideration reached RMB 33.03 million, implying a volume-weighted average cost of roughly RMB 39.62 per share. All repurchased shares are being held as treasury shares.\nFollowing this transaction, the company’s treasury stock increased from 23.67 million to 24.50 million shares. The number of issued shares outstanding (excluding treasury shares) declined from 714.23 million to 713.40 million, a reduction of 0.12%. Total issued share capital remains unchanged at 737.90 million shares, as the repurchased shares have not been cancelled.\nThe filing affirms that the repurchase complied with both Hong Kong Stock Exchange rules and the relevant Shenzhen Stock Exchange regulations. No additional information regarding the repurchase mandate or future issuance restrictions was provided in the disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191083280","isCrawlerRequest":true}